Options for temporary mechanical circulatory support

Journal of Thoracic Disease

Volumn 7, Issue 12, 2015, Pages 2102-2111

  Saffarzadeh, Areo ^a   Bonde, Pramod ^a  

^a YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Biventricular assist device (BIVAD); CentriMag; Extracorporeal membrane oxygenation (ECMO); Left ventricular assist device (LVAD); Percutaneous ventricular assist device (pVAD); Right ventricular assist device (RVAD); TandemHeart

Indexed keywords

ACUTE HEART INFARCTION; AIR EMBOLISM; AORTA DISSECTION; AORTA RUPTURE; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; ARTERY OCCLUSION; ASSISTED CIRCULATION; BLOOD PUMP; CARDIOGENIC SHOCK; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; GAS EMBOLISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART TAMPONADE; HEART VENTRICLE ARRHYTHMIA; HEMOLYSIS; HUMAN; HYPOXIA; INFECTION; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL DEVICE COMPLICATION; PERIPHERAL VASCULAR DISEASE; PUMP MIGRATION; REVIEW; STERNOTOMY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VASCULAR DISEASE;

EID: 84954143648     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.09.14     Document Type: Review

References (22)

1. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:113-8.
2. Stretch R, Sauer CM, Yuh DD, et al. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 2014;64:1407-15.
3. Bellumkonda L, Bonde P. Ventricular assist device therapy for heart failure-past, present, and future. Int Anesthesiol Clin 2012;50:123-45.
4. Gilotra NA, Stevens GR. Temporary mechanical circulatory support: a review of the options, indications, and outcomes. Clin Med Insights Cardiol 2015;8:75-85.
5. Abnousi F, Yong CM, Fearon W, et al. The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock. Curr Cardiol Rep 2015;17:40.
6. Estep JD, Cordero-Reyes AM, Bhimaraj A, et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail 2013;1:382-8.
7. Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol 2015;65:e7-e26.
8. Severi L, Vaccaro P, Covotta M, et al. Severe intra-aortic balloon pump complications: a single-center 12-year experience. J Cardiothorac Vasc Anesth 2012;26:604-7.
9. Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009;30:459-68.
10. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012;367:1287-96.
11. Lauten A, Engström AE, Jung C, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 2013;6:23-30.
12. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012;126:1717-27.
13. Kapur NK, Paruchuri V, Urbano-Morales JA, et al. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation 2013;128:328-36.
14. Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e1-8.
15. Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011;57:688-96.
16. Sauer CM, Yuh DD, Bonde P. Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J 2015;61:31-6.
17. Koeckert MS, Jorde UP, Naka Y, et al. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg 2011;26:666-8.
18. Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 2014;97:610-6.
19. Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 2015;36:2246-56.
20. Borisenko O, Wylie G, Payne J, et al. Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: a systematic literature review and meta-analysis of observational studies. ASAIO J 2014;60:487-97.
21. Mohite PN, Zych B, Popov AF, et al. CentriMag shortterm ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days. Eur J Cardiothorac Surg 2013;44:e310-5.
22. Takayama H, Soni L, Kalesan B, et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail 2014;7:799-806.